Newswise Feature Channel: Immunology

Senescence is a state in which stressed cells stop dividing but remain alive. New findings reveal that the underlying process unfolds in distinct stages that depend on the type of drug used, and show how a new class of drugs triggers inflammation.

A new study from the Yale Department of Pathology and Department of Ophthalmology and Visual Sciences suggests that immune cells that live at the borders of the brain are shaped not only by inflammatory signals, but also by the physical environment of the tissues they inhabit.

Scientists at Sanford Burnham Prebys Medical Discovery Institute, Mayo Clinic and their international collaborators published findings July 29, 2026, in Nature revealing a new connection between energy-producing mitochondria and chronic inflammation during aging. They also found that blocking a related gene reduced inflammation and promoted healthier aging in mice.

Galvanize Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced two new peer-reviewed publications that add to the growing body evidence suggesting Aliya PEF may do more than ablate tissue locally - it may also be immune system activating.

In a new study, scientists from Johns Hopkins Medicine report that an experimental mRNA-based platform has the potential to help deliver next-generation mRNA therapeutics, including vaccines fighting against infectious disease, cancer and autoimmune conditions, faster and more efficiently than the industry standard.

In people with type 1 diabetes, the immune system mistakenly destroys the pancreatic beta cells responsible for producing insulin. Patients therefore require lifelong insulin therapy to regulate their blood glucose levels.

Bacteria in lung tumors may boost the activation of innate immune cells in the presence of a common vitamin metabolite, according to a preclinical study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Researchers at Washington University School of Medicine in St. Louis have discovered lymph node-like structures in the skull bone marrow of mice for the first time and demonstrated that they act as rapid first responders against brain cancer before distant lymph nodes get the signal that abnormal cells are present. The researchers also found evidence of similar immune cells in human skull bone ma…

The Wistar Institute announces the appointment of Brian Fuglestad, Ph.D., as associate professor in the Center for Advanced Therapeutics (CAT). Fuglestad uses biophysical and biochemical approaches to study proteins at the molecular and atomic level.

Having completed their phase 1b clinical trial in psoriasis, with outstanding results, SFA Therapeutics, Inc. is now positioning itself for the commercial development of SFA-002D, a drug that has the potential to reset the immune system. This drug has shown significant results in the treatment of psoriasis, as a proof of concept for application of the platform in multiple autoimmune diseases. SFA…

The National Cancer Institute recognizes UC Davis Comprehensive Cancer Center among the nation's elite and awards nearly $18 million grant.

New research reports that immune responses produced in the lymph nodes shared by the liver, pancreas, and intestine shape T-cell tolerance, pointing to potential new approaches for hard-to-treat pancreatic cancers.

A conversation with Erin Adams, PhD, as she begins her tenure as Chair of the Department of Biochemistry and Molecular Biology.

Infectious diseases specialists including Anna Sick-Samuels and Aaron Milstone from Johns Hopkins Children's Center, report results of a new federally funded study of EAC culture ordering that suggests it is safe to test less under certain conditions in pediatric intensive care units.

Calcinosis cutis is a condition that causes calcium deposits in a person's skin or soft tissues.

A new Phase I clinical trial has found that an emerging immunotherapy is promising for the treatment of recurrent glioblastoma, a highly aggressive and fatal brain cancer.

RWJBarnabas Health is partnering with the New Jersey Department of Health (NJDOH) to launch Stay Well. Learn Well., a comprehensive back-to-school initiative offering vaccinations and school physicals to help ensure children across the state begin the school year healthy, protected and ready to learn.

A plant-derived compound found in Hudi enteric-coated capsule (HDEC) may offer a new way to rebalance immune responses in ulcerative colitis (UC). In mouse models of chronic intestinal inflammation, HDEC and its major bioactive constituent, polydatin, reduced disease severity and mucosal injury. The study traced polydatin's action to Kelch-like ECH-associated protein 1 (KEAP1), which directly bin…